References
- Kramer PD. Listening to Prozac: a psychiatrist explores antidepressant drugs and the remaking of the self. Viking Penguin, New York 1993; 246–9
- Dorland's illustrated medical dictionary26th ed. WB Saunders, Philadelphia 1985; 1014
- Giurgea C. Vers une pharmacologic de l'activité intégrative du cerveau. Tentative du concept nootrope en psychopharmacologie. Actual Pharmacol 1972; 25: 115–56
- Akiskal HS, Hirschfeld R M A, Yerevanian BI. The relationship of personality to affective disorders: a critical review. Arch Gen Psychiatry 1983; 40: 801–10
- Frances AJ, Widiger T. Methodological issues in personality disorder diagnosis. Contemporary directions in psychopathology, T Millon, G Herman. Guilford Press, New York 1986; 301–400
- Stein G. Drug treatment of the personality disorders. Br J Psychiatry 1992; 161: 167–84
- Deltito JA, Stam M. Psychopharmacological treatment of avoidant personality disorder. Compr Psychiatry 1989; 30: 498–504
- Goldberg SC, Schulz SC, Schulz PM, Resnick RJ, Harmer RM, Friedel RO. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs. placebo. Arch Gen Psychiatry 1986; 43: 680–6
- Soloff PH, George A, Nathan RS, Schulz PM, Ulrich RF, Perel JM. Progress in pharmacotherapy of borderline disorders: a double-blind study of amitriptyline, haloperidol and placebo. Arch Gen Psychiatry 1986; 43: 691–7
- Soloff PH, Anselm G, Nathan RS, Schulz PM, Perel JM. Paradoxical effect of amitriptyline on borderline patients. Am J Psychiatry 1986; 143: 1603–5
- Cowdry R, Gardner DL. Pharmacotherapy of borderline personality disorder. Arch Gen Psychiatry 1988; 45: 111–9
- Soloff PH, Cornelius JR, George A, Nathan S, Perel JM, Ulrich RF. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 1993; 50: 377–85
- Cornelius JR, Soloff PH, Perel JM, Ulrich RF. Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine. Am J Psychiatry 1993; 150: 1843–8
- Cornelius JR, Soloff PH, Perel JM, Ulrich RF. A preliminary trial of fluoxetine in refractory borderline patients. J Clin Psychopharmacol 1991; 11: 116–20
- Markovitz PJ, Calabrese JR, Schulz SC, Meltzer HY. Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am J Psychiatry 1991; 148: 1064–7
- Norden MJ. Fluoxetine in borderline personality disorder. Prog Neuropsychopharmacol Biol Psychiatry 1989; 13: 885–93
- Fava M, Rosenbaum JF, Pava JA, McCarthy MK, Steingard RJ, Bouffides E. Anger attacks in unipolar depression, part 1: clinical correlates and responses to fluoxetine treatment. Am J Psychiatry 1993; 150: 1158–63